Skip to main content
. 2020 Dec 11;28(4):189–198. doi: 10.12793/tcp.2020.28.e18

Figure 1. Selection of drugs for comparison between the pharmacogenomics guidelines and drug labels of the regulatory affairs.

Figure 1

CPIC, Clinical Pharmacogenetics Implementation Consortium; DPWG, Dutch Pharmacogenetics Working Group; FDA, US Food and Drug Administration; MFDS, Korea Ministry of Food and Drug Safety.